INNT
TOTAL INVALIDATION PROCESSED BY THE IB
22/08/2025
Voltar para busca
Dado oficial do USPTO
TISSUE LIFE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
23/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
07/03/2017
Data de registro
06/02/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/08/2024
Última transação
23/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
81
Localização do titular
AU
Examinador
LEE, DOUGLAS
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Australian Biotechnologies Pty Limited
Representantes
Jami A. Gekas Foley & Lardner LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
biological products for medical use, namely, biological tissue grafts; biological bone implant material; bone graft substitutes; biological tissue cultures for medical purposes; implant materials for use in guided tissue regeneration in surgery, namely, implants comprising living tissue; biological tissue cultures for medical purposes; biological bone replacement tissue intended for subsequent implantation; surgical bone graft materials comprised of living tissue; guided tissue regeneration materials in the nature of medicaments to help assist with guided tissue regeneration; implant materials for use in guided tissue regeneration in surgery in the nature of medicaments to help assist with guided tissue regeneration in surgery; implantable textile material comprising primarily of living tissue to encourage the growth of tissue; implants comprised of living tissue for guided tissue regeneration; surgical grafts comprised of living tissues; surgical implants comprised of living tissues; surgical implants comprised of living tissues; surgical implants comprised of living tissues grown from stem; tissue-regenerative medical preparations; implants comprised of living tissues for transplants; biological bone implant material
Classe 42
medical laboratory services; biological laboratory services; research and development in the field of biological products, tissue cultures and regeneration materials for medical use and in surgery, implant and transplant materials, surgical graft materials and tissue-regenerative medical preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/08/2025
INPC
INVALIDATION PROCESSED
05/08/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
23/04/2025
C71T
CANCELLED SECTION 71
23/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/03/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/02/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/06/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/05/2018
FIMP
FINAL DISPOSITION PROCESSED
14/05/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/11/2017
PUBO
PUBLISHED FOR OPPOSITION
21/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/11/2017
ALIE
ASSIGNED TO LIE
12/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
23/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
23/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/09/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/09/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2017
RFNT
REFUSAL PROCESSED BY IB
28/07/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/07/2017
RFRR
REFUSAL PROCESSED BY MPU
10/07/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/06/2017
MAFR
APPLICATION FILING RECEIPT MAILED
30/06/2017
CNRT
NON-FINAL ACTION WRITTEN
29/06/2017
DOCK
ASSIGNED TO EXAMINER
27/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/06/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/06/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TISSUE LIFE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.